Expertise in
3
conditions

Myrna Candelaria

Rancho El Pedregal, MEX, MX 
Expertise in
3
conditions
Rancho El Pedregal, MEX, MX 

Overview

Myrna Candelaria practices practicing medicine in Rancho El Pedregal, Mexico.

Ms. Candelaria is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Follicular Lymphoma.

She is actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Rancho El Pedregal, MEX, Mexico
Other Locations
Mexico City, DIF, Mexico
Mexico, MEX 14080, Mexico
Paso Nacional, OAX, Mexico
Av San Fernando 22, Tlalpan, DIF 14370, Mexico
Av. San Fernando 22. Col. Sección XVI. Tlalpan, San Fernando, DIF 14080, Mexico
Av. San Fernando No. 22, DF, San Fernando, MEX, Mexico
Tlalpan, VER, Mexico

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Valganciclovir for Suppression of HHV-8 Four Weeks Prior to Initiation of cART in Patients With Disseminated Kaposi Sarcoma Compare With Standard Therapy, Its Impact on the Development of IRIS and Attributable Mortality
Valganciclovir for Suppression of HHV-8 Four Weeks Prior to Initiation of cART in Patients With Disseminated Kaposi Sarcoma Compare With Standard Therapy, Its Impact on the Development of IRIS and Attributable Mortality
Enrollment Status: Completed
Publish Date: January 27, 2022
Intervention Type: Drug
Study Drugs: Valganciclovir, Antiretroviral Combinations
Study Phase: Phase 2

37 Total Publications

The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy.
The role of EZH2 dysregulation in the pathogenesis of B-cell lymphomas and its implications as a target therapy.
Journal: Frontiers in oncology
Published: March 30, 2026

Frequently Asked Questions about Myrna Candelaria

Is Myrna Candelaria a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Myrna Candelaria is classified as an Distinguished expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Myrna Candelaria participate in research or clinical trials?

Yes. Myrna Candelaria has published 37 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of Myrna Candelaria's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Candelaria's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile